Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

CompletedOBSERVATIONAL
Enrollment

442

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 19, 2021

Study Completion Date

February 19, 2021

Conditions
Cerebrotendinous Xanthomatosis (CTX)
Trial Locations (44)

10467

Travere Investigational Site, The Bronx

19104

Travere Investigational Site, Philadelphia

19107

Travere Investigational Site, Philadelphia

21201

Travere Investigational Site, Baltimore

23298

Travere Investigational Site, Richmond

23502

Travere Investigational Site, Norfolk

26506

Travere Investigational Site, Morgantown

27517

Travere Investigational Site, Chapel Hill

27708

Travere Investigational Site, Durham

29425

Travere Investigational Site, Charleston

30322

Travere Investigational Site, Atlanta

32207

Travere Investigational Site, Jacksonville

32608

Travere Investigational Site, Gainesville

35294

Travere Investigational Site, Birmingham

37232

Travere Investigational Site, Nashville

38103

Travere Investigational Site, Germantown

40202

Travere Investigational Site, Louisville

43205

Travere Investigational Site, Columbus

44106

Travere Investigational Site, Cleveland

45229

Travere Investigational Site, Cincinnati

46202

Travere Investigational Site, Indianapolis

48105

Travere Investigational Site, Ann Arbor

48201

Travere Investigational Site, Detroit

52242

Travere Investigational Site, Iowa City

53226

Travere Investigational Site, Milwaukee

60611

Travere Investigational Site, Chicago

63103

Travere Investigational Site, St Louis

64108

Travere Investigational Site, Kansas City

70121

Travere Investigational Site, New Orleans

73104

Travere Investigational Site, Oklahoma City

77025

Travere Investigational Site, Houston

77030

Travere Investigational Site, Houston

80045

Travere Investigational Site, Aurora

84113

Travere Investigational Site, Salt Lake City

90027

Travere Investigational Site, Los Angeles

90095

Travere Investigational Site, Los Angeles

92093

Travere Investigational Site, La Jolla

94303

Travere Investigational Site, Palo Alto

97223

Travere Investigational Site, Tigard

98105

Travere Investigational Site, Seattle

98405

Travere Investigational Site, Tacoma

99204

Travere Investigational Site, Spokane

02115

Travere Investigational Site, Boston

97239-3098

Travere Investigational Site, Portland

All Listed Sponsors
lead

Travere Therapeutics, Inc.

INDUSTRY

NCT02638220 - Cerebrotendinous Xanthomatosis (CTX) Prevalence Study | Biotech Hunter | Biotech Hunter